{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:27:45Z","timestamp":1791919665855,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T00:00:00Z","timestamp":1344297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T00:00:00Z","timestamp":1344297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1038\/mp.2012.115","type":"journal-article","created":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T08:39:29Z","timestamp":1344328769000},"page":"882-888","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Latrepirdine stimulates autophagy and reduces accumulation of \u03b1-synuclein in cells and in mouse brain"],"prefix":"10.1038","volume":"18","author":[{"given":"J W","family":"Steele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Lachenmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Liken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S H","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I E","family":"Alfaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bernales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Verdile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bharadwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Friss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Dolios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Ringe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A A","family":"Protter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R N","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M E","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G A","family":"Petsko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,7]]},"reference":[{"key":"BFmp2012115_CR1","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/BF02434871","volume":"129","author":"NN Lermontova","year":"2000","unstructured":"Lermontova NN, Lukoyanov NV, Serkova TP, Lukoyanova EA, Bachurin SO . Dimebon improves learning in animals with experimental Alzheimer's disease. Bull Exp Biol Med 2000; 129: 544\u2013546.","journal-title":"Bull Exp Biol Med"},{"key":"BFmp2012115_CR2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1023\/B:BEBM.0000017097.75818.14","volume":"136","author":"VV Grigorev","year":"2003","unstructured":"Grigorev VV, Dranyi OA, Bachurin SO . Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons. Bull Exp Biol Med 2003; 136: 474\u2013477.","journal-title":"Bull Exp Biol Med"},{"key":"BFmp2012115_CR3","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1124\/jpet.109.164491","volume":"333","author":"M Giorgetti","year":"2010","unstructured":"Giorgetti M, Gibbons JA, Bernales S, Alfaro IE, Drieu La Rochelle C, Cremers T et al. Cognition-enhancing properties of dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonism. J Pharmacol Exp Ther 2010; 333: 748\u2013757.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFmp2012115_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1750-1326-6-7","volume":"6","author":"J Wang","year":"2011","unstructured":"Wang J, Ferruzzi MG, Varghese M, Qian X, Cheng A, Xie M et al. Preclinical study of dimebon on beta-amyloid-mediated neuropathology in Alzheimer's disease. Mol Neurodegener 2011; 6: 7.","journal-title":"Mol Neurodegener"},{"key":"BFmp2012115_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1749-6632.2001.tb03654.x","volume":"939","author":"S Bachurin","year":"2001","unstructured":"Bachurin S, Bukatina E, Lermontova N, Tkachenko S, Afanasiev A, Grigoriev V et al. Antihistamine agent dimebon as a novel neuroprotector and a cognition enhancer. Ann NY Acad Sci 2001; 939: 425\u2013435.","journal-title":"Ann NY Acad Sci"},{"key":"BFmp2012115_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1750-1326-3-15","volume":"3","author":"J Wu","year":"2008","unstructured":"Wu J, Li Q, Bezprozvanny I . Evaluation of dimebon in cellular model of Huntington's disease. Mol Neurodegener 2008; 3: 15.","journal-title":"Mol Neurodegener"},{"key":"BFmp2012115_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.06.018","volume":"142","author":"AA Pieper","year":"2010","unstructured":"Pieper AA, Xie S, Capota E, Estill SJ, Zhong J, Long JM et al. Discovery of a prone urogenic, neuroprotective chemical. Cell 2010; 142: 39\u201351.","journal-title":"Cell"},{"key":"BFmp2012115_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0140-6736(08)61074-0","volume":"372","author":"RS Doody","year":"2008","unstructured":"Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO et al. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study. Lancet 2008; 372: 207\u2013215.","journal-title":"Lancet"},{"key":"BFmp2012115_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1001\/archneurol.2009.334","volume":"67","author":"K Kieburtz","year":"2010","unstructured":"Kieburtz K, McDermott MP, Voss TS, Corey-Bloom J, Deuel LM, Dorsey ER et al. A randomized, placebo-controlled trial of latrepirdine in Huntington disease. Arch Neurol 2010; 67: 154\u2013160.","journal-title":"Arch Neurol"},{"key":"BFmp2012115_CR10","unstructured":"Bharadwaj P, Verdile G, Barr RK, Gupta V, Steele JW, Lachenmayer ML et al. Latrepirdine (Dimebon\u2122) enhances autophagy and reduces intracellular GFP-A\u03b242 levels in yeast. J Alzheimer's Disease (in press)."},{"key":"BFmp2012115_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12640-011-9299-y","volume":"22","author":"SO Bachurin","year":"2012","unstructured":"Bachurin SO, Shelkovnikova TA, Ustyugov AA, Peters O, Khritankova I, Afanasieva MA et al. Dimebon slows progression of proteinopathy in gamma-synuclein transgenic mice. Neurotox Res 2012; 22: 33\u201342.","journal-title":"Neurotox Res"},{"key":"BFmp2012115_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2174\/0929866043407174","volume":"11","author":"DM Walsh","year":"2004","unstructured":"Walsh DM, Selkoe DJ . Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Peptide Lett 2004; 11: 213\u2013228.","journal-title":"Protein Peptide Lett"},{"key":"BFmp2012115_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF03033777","volume":"7","author":"M Broe","year":"2005","unstructured":"Broe M, Shepherd CE, Mann DM, Milward EA, Gai WP, Thiel E et al. Insoluble alpha-synuclein in Alzheimer's disease without Lewy body formation. Neurotox Res 2005; 7: 69\u201376.","journal-title":"Neurotox Res"},{"key":"BFmp2012115_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","volume":"65","author":"H Uchikado","year":"2006","unstructured":"Uchikado H, Lin WL, DeLucia MW, Dickson DW . Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 2006; 65: 685\u2013697.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFmp2012115_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0278-5846(02)00339-1","volume":"27","author":"O Wirths","year":"2003","unstructured":"Wirths O, Bayer TA . Alpha-synuclein, Abeta and Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 103\u2013108.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFmp2012115_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels T, Choi JG, Selkoe DJ . Alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 2011; 477: 107\u2013110.","journal-title":"Nature"},{"key":"BFmp2012115_CR17","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1096\/fj.10-175158","volume":"25","author":"Y Tian","year":"2011","unstructured":"Tian Y, Bustos V, Flajolet M, Greengard P . A small-molecule enhancer of autophagy decreases levels of Abeta and APP-CTF via Atg5-dependent autophagy pathway. FASEB J 2011; 25: 1934\u20131942.","journal-title":"FASEB J"},{"key":"BFmp2012115_CR18","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nchembio883","volume":"3","author":"S Sarkar","year":"2007","unstructured":"Sarkar S, Perlstein EO, Imarisio S, Pineau S, Cordenier A, Maglathlin RL et al. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol 2007; 3: 331\u2013338.","journal-title":"Nat Chem Biol"},{"key":"BFmp2012115_CR19","unstructured":"Steele JW, Lachenmayer ML, Ju S, Stock A et al. Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model. submitted manuscript."},{"key":"BFmp2012115_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1750-1326-4-51","volume":"4","author":"JW Steele","year":"2009","unstructured":"Steele JW, Kim SH, Cirrito JR, Verges DK, Restivo JL, Westaway D et al. Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo. Mol Neurodegener 2009; 4: 51.","journal-title":"Mol Neurodegener"},{"key":"BFmp2012115_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/978-1-59745-466-7_24","volume":"390","author":"DJ Klionsky","year":"2007","unstructured":"Klionsky DJ . Monitoring autophagy in yeast: the Pho8Delta60 assay. Methods Mol Biol 2007; 390: 363\u2013371.","journal-title":"Methods Mol Biol"},{"key":"BFmp2012115_CR22","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/j.1471-4159.2009.06054.x","volume":"109","author":"K Vekrellis","year":"2009","unstructured":"Vekrellis K, Xilouri M, Emmanouilidou E, Stefanis L . Inducible over-expression of wild type alpha-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death. J Neurochem 2009; 109: 1348\u20131362.","journal-title":"J Neurochem"},{"key":"BFmp2012115_CR23","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.1090439","volume":"302","author":"TF Outeiro","year":"2003","unstructured":"Outeiro TF, Lindquist S . Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 2003; 302: 1772\u20131775.","journal-title":"Science"},{"key":"BFmp2012115_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cell.2005.03.008","volume":"121","author":"M Tanaka","year":"2005","unstructured":"Tanaka M, Chien P, Yonekura K, Weissman JS . Mechanism of cross-species prion transmission: an infectious conformation compatible with two highly divergent yeast prion proteins. Cell 2005; 121: 49\u201362.","journal-title":"Cell"},{"key":"BFmp2012115_CR25","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1074\/jbc.273.7.3963","volume":"273","author":"T Noda","year":"1998","unstructured":"Noda T, Ohsumi Y . Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J Biol Chem 1998; 273: 3963\u20133966.","journal-title":"J Biol Chem"},{"key":"BFmp2012115_CR26","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.bbamcr.2009.01.016","volume":"1793","author":"Z Yue","year":"2009","unstructured":"Yue Z, Friedman L, Komatsu M, Tanaka K . The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases. Biochim Biophys Acta 2009; 1793: 1496\u20131507.","journal-title":"Biochim Biophys Acta"},{"key":"BFmp2012115_CR27","doi-asserted-by":"publisher","first-page":"7437","DOI":"10.1073\/pnas.89.16.7437","volume":"89","author":"MF Knauer","year":"1992","unstructured":"Knauer MF, Soreghan B, Burdick D, Kosmoski J, Glabe CG . Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4\/beta protein. Proc Natl Acad Sci USA 1992; 89: 7437\u20137441.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2012115_CR28","doi-asserted-by":"publisher","first-page":"14508","DOI":"10.1523\/JNEUROSCI.1560-11.2011","volume":"31","author":"D Ebrahimi-Fakhari","year":"2011","unstructured":"Ebrahimi-Fakhari D, Cantuti-Castelvetri I, Fan Z, Rockenstein E, Masliah E, Hyman BT et al. Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of alpha-synuclein. J Neurosci 2011; 31: 14508\u201314520.","journal-title":"J Neurosci"},{"key":"BFmp2012115_CR29","doi-asserted-by":"publisher","first-page":"7585","DOI":"10.1523\/JNEUROSCI.5809-11.2012","volume":"32","author":"LG Friedman","year":"2012","unstructured":"Friedman LG, Lachenmayer ML, Wang J, He L, Poulose SM, Komatsu M et al. Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of \u03b1-synuclein and LRRK2 in the brain. J Neurosci 2012; 32: 7585\u20137593.","journal-title":"J Neurosci"},{"key":"BFmp2012115_CR30","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1126\/science.327.5971.1309","volume":"327","author":"G Miller","year":"2010","unstructured":"Miller G . Pharmacology. The puzzling rise and fall of a dark-horse Alzheimer's drug. Science 2010; 327: 1309.","journal-title":"Science"},{"key":"BFmp2012115_CR31","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1126\/science.1129462","volume":"313","author":"AA Cooper","year":"2006","unstructured":"Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 2006; 313: 324\u2013328.","journal-title":"Science"},{"key":"BFmp2012115_CR32","doi-asserted-by":"publisher","first-page":"e1001052","DOI":"10.1371\/journal.pbio.1001052","volume":"9","author":"S Ju","year":"2011","unstructured":"Ju S, Tardiff DF, Han H, Divya K, Zhong Q, Maquat LE et al. A yeast model of FUS\/TLS-dependent cytotoxicity. PLoS Biol 2011; 9: e1001052.","journal-title":"PLoS Biol"},{"key":"BFmp2012115_CR33","doi-asserted-by":"publisher","first-page":"6439","DOI":"10.1073\/pnas.0802082105","volume":"105","author":"BS Johnson","year":"2008","unstructured":"Johnson BS, McCaffery JM, Lindquist S, Gitler AD . A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc Natl Acad Sci USA 2008; 105: 6439\u20136444.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2012115_CR34","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1126\/science.1090389","volume":"302","author":"S Willingham","year":"2003","unstructured":"Willingham S, Outeiro TF, DeVit MJ, Lindquist SL, Muchowski PJ . Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science 2003; 302: 1769\u20131772.","journal-title":"Science"},{"key":"BFmp2012115_CR35","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1083\/jcb.200606084","volume":"175","author":"C He","year":"2006","unstructured":"He C, Song H, Yorimitsu T, Monastyrska I, Yen WL, Legakis JE et al. Recruitment of Atg9 to the preautophagosomal structure by Atg11 is essential for selective autophagy in budding yeast. J Cell Biol 2006; 175: 925\u2013935.","journal-title":"J Cell Biol"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp2012115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2012115","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2012115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:04:24Z","timestamp":1648782264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2012115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,7]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["BFmp2012115"],"URL":"https:\/\/doi.org\/10.1038\/mp.2012.115","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,7]]},"assertion":[{"value":"24 April 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AAP is Vice President of Preclinical Development for Medivation. SG holds research grant support from Amicus Pharmaceuticals and is a consultant to the Pfizer-Janssen Alzheimer's Immunotherapy Alliance. GAP is on the scientific advisory boards of Amicus Pharmaceuticals and Neurophage. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}